![](/img/cover-not-exists.png)
838-2 Rofecoxib increases cardiovascular events in arthritis patients but celecoxib and nonspecific nonsteroidal anti-inflammatory drugs do not: Results from a large new England health care claims database
Andrew Whelton, William M Spalding, William B White, Matthew J Reeves, Sandy S Suh, John G FortVolume:
43
Year:
2004
Language:
english
DOI:
10.1016/s0735-1097(04)91751-2
File:
PDF, 45 KB
english, 2004